Loading live market data…

Xeris Biopharma Holdings, Inc.

NASDAQ:XERS

$8.7 USD

$0.42 (5.07%)

Volume
1.42M
Average Volume
1.88M
Market Capitalization
$1.5B
P/E Ratio
122.88
Dividend Yield
0.00%
Price Target
$6.60
Year High
$10.08
Year Low
$4.87
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.12

XERS Estimated and Actual Revenue by Quarter

XERS Estimated and Actual EPS by Quarter

XERS Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 2 -51.08M -49.68M -50.26M -59.57M -57.94M -58.61M
2028-09-30 1 -49.69M -48.33M -48.89M -57.95M -56.36M -57.02M
2028-06-30 1 -45.38M -44.13M -44.65M -52.92M -51.47M -52.07M
2028-03-31 2 -44.1M -42.89M -43.39M -51.43M -50.02M -50.6M
2027-12-31 3 -49.78M -48.42M -48.98M -58.06M -56.47M -57.13M
2027-09-30 2 -44.99M -43.76M -44.27M -52.47M -51.03M -51.63M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 2 24.5M 25.4M 24.87M 168.63M 173.38M 170.6M
2028-09-30 1 22.75M 23.58M 23.09M 164.05M 168.66M 165.96M
2028-06-30 1 14M 14.51M 14.21M 149.8M 154.02M 151.55M
2028-03-31 2 15.75M 16.33M 15.99M 145.58M 149.67M 147.27M
2027-12-31 3 25.72M 26.67M 26.11M 164.35M 168.97M 166.26M
2027-09-30 2 18.55M 19.23M 18.83M 148.53M 152.71M 150.26M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 2 138.09M 141.98M 139.7M 1 0.13791 0.14297 0.14
2028-09-30 1 134.34M 138.12M 135.9M 1 0.12806 0.13276 0.13
2028-06-30 1 122.67M 126.12M 124.1M 1 0.07880321 0.08169617 0.08
2028-03-31 2 119.21M 122.57M 120.6M 1 0.08865361 0.09190819 0.09
2027-12-31 3 134.58M 138.37M 136.15M 1 0.1448 0.15012 0.147
2027-09-30 2 121.63M 125.06M 123.05M 1 0.10441 0.10825 0.106